PitchBook-2025年二季度Agtech公共资产负债表和估值指南（英）-2025_9页_603kb

Summary of Agtech Q2 2025 Public Comp Sheet and Valuation Guide

Key Insights

• Trade and Tariff Policies: Trump administration tariffs on Norwegian salmon (effective April 2025) created uncertainty in agricultural exports, negatively impacting soybean farmers but providing opportunities for US-based land-based salmon producers like Atlantic Sapphire. This led to higher costs for imported salmon and competitive advantages for domestic companies.
• Farm Bill Effects: The One Big Beautiful Bill Act (signed in July 2025) offers permanent R&D expensing and depreciation benefits, improving cash flow for agtech firms. However, it primarily supports large commodity producers, which may reduce adoption of new technologies among small and mid-sized farms, constraining short-term market growth.
• Stock Performance: Agtech stocks underperformed broader market indexes (e.g., S&P 500) in Q2 2025, with a median quarterly return of 6%, compared to 10% for the S&P 500. Animal agriculture outperformed, with a median 16% quarterly increase, driven by operational improvements at companies like Atlantic Sapphire.
• Revenue and Profitability Trends: Animal agriculture showed strong revenue recovery (expected 13% YoY growth in 2025) and expanding margins due to scale and cost management. Industrial biotech saw acceleration in EBITDA growth, from 2% in 2024 to projected 14% by 2026, with companies improving profitability and cash flow generation.
• Valuation Overview: Agtech sectors vary in valuation, with animal agriculture and animal biotech commanding higher multiples based on historical revenue and EBITDA data, reflecting investor enthusiasm for sustainable practices and growth prospects.
• Investment Outlook: Focus on areas like aquaculture, plant-based foods, and sustainable agriculture for future growth, supported by policy changes and market dynamics.

Sources: PitchBook and Morningstar data for Q2 2025.